12:00 AM
 | 
Jun 03, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Invokana canagliflozin regulatory update

Mitsubishi Tanabe submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) for canagliflozin to treat Type II diabetes. FDA...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >